Ledger.Open graph →
SEC Form D · Amendment · filed June 13, 2022

GLO Pharma, Inc

Offering
$33.0M
Sold
$33.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Carlsbad, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Carol Shen · Carlsbad, CADirectorNicole Quinn · Carlsbad, CADirectorDayna Quanbeck · Carlsbad, CADirectorScott Glenn · Carlsbad, CAExec · DirectorLauren Otsuki · Carlsbad, CADirectorDan Dearborn · Tampa, FLExec · DirectorMichael Scott · SAN FRANCISCO, CADirectorDerive Ventures GP I, LLC · SAN FRANCISCO, CADirectorJeff Stinson · Little Rock, ARDirectorDayna Quanbeck · Carlsbad, CADirectorJacob B. Jones · Raleigh, NCDirectorGordon V. Tucker · Raleigh, NCDirectorJeffrey G. Brock · Raleigh, NCDirectorSteve Howard · Singapore, U0Exec · DirectorSriram Krishnan · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗